Literature DB >> 7426586

Benign familial fleck retina.

S F Sabel Aish, B Dajani.   

Abstract

A family with a benign form of fleck retina is described. Seven out of 10 siblings were affected. The consanguinious parents were both normal. The fundi were massively invaded by lesions which appeared as discrete, bright white or yellow flecks situated well behind the retinal blood vessels. The macula was always free. Fluorescein studies revealed a healthy macula and retinal and choroidal blood vessels. The relationship of this benign form to the other forms of fleck retina is discussed.

Entities:  

Mesh:

Year:  1980        PMID: 7426586      PMCID: PMC1043787          DOI: 10.1136/bjo.64.9.652

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Fluorescein studies in fundus flavimaculatus and drusen.

Authors:  J T Ernest; A E Krill
Journal:  Am J Ophthalmol       Date:  1966-07       Impact factor: 5.258

2.  [Fundus flavimaculatus].

Authors:  A Franceschetti; J François
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1965-09

3.  Clinical demonstrations.

Authors:  J François
Journal:  Ophthalmologica       Date:  1970       Impact factor: 3.250

4.  Fundus flavimaculatus. Two familial cases with macular degeneration.

Authors:  N Brown; D W Hill
Journal:  Br J Ophthalmol       Date:  1968-11       Impact factor: 4.638

5.  Doyne's honeycomb retinal degeneration. Clinical and genetic features.

Authors:  W G Pearce
Journal:  Br J Ophthalmol       Date:  1968-02       Impact factor: 4.638

6.  Dominantly inherited drusen of Bruch's membrane.

Authors:  A F Deutman; L M Jansen
Journal:  Br J Ophthalmol       Date:  1970-06       Impact factor: 4.638

7.  Flecked retina syndrome.

Authors:  A E Krill; B A Klien
Journal:  Arch Ophthalmol       Date:  1965-10

8.  [Fundus flavimaculatus].

Authors:  H Kment; P Amalric; H Remky
Journal:  Klin Monbl Augenheilkd       Date:  1967       Impact factor: 0.700

9.  Fundus flavimaculatus. Clinical, functional and histopathologic observations.

Authors:  B A Klien; A E Krill
Journal:  Am J Ophthalmol       Date:  1967-07       Impact factor: 5.258

10.  [Fundus flavi-maculatus. (Presentation of retinographies)].

Authors:  A Brini
Journal:  Bull Soc Ophtalmol Fr       Date:  1966-02
View more
  6 in total

1.  Brown's syndrome as a complication of cardiopulmonary resuscitation.

Authors:  K M Brady; D A Hiles
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

2.  Benign fleck retina.

Authors:  T W Isaacs; I L McAllister; M S Wade
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

3.  Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retina.

Authors:  Panagiotis I Sergouniotis; Alice E Davidson; Donna S Mackay; Eva Lenassi; Zheng Li; Anthony G Robson; Xu Yang; Jaimie Hoh Kam; Timothy W Isaacs; Graham E Holder; Glen Jeffery; Jonathan A Beck; Anthony T Moore; Vincent Plagnol; Andrew R Webster
Journal:  Am J Hum Genet       Date:  2011-12-01       Impact factor: 11.025

4.  Benign panretinal uniform radial linear-shaped flecks.

Authors:  Suzanna Airiani; Wener Cella; Chai Lin Chou; Joaquin Tosi; Stephen H Tsang
Journal:  Clin Exp Ophthalmol       Date:  2008-12       Impact factor: 4.207

5.  Multimodal imaging including optical coherence tomography angiography of benign familial fleck retina.

Authors:  George J Manayath; Shishir Verghese; Hirika Vipul Gosalia; Anuradha Kanakath; Venkatapathy Narendran
Journal:  Oman J Ophthalmol       Date:  2022-03-02

6.  Impact of Next Generation Sequencing in Unraveling the Genetics of 1036 Spanish Families With Inherited Macular Dystrophies.

Authors:  Marta Del Pozo-Valero; Rosa Riveiro-Alvarez; Inmaculada Martin-Merida; Fiona Blanco-Kelly; Saoud Swafiri; Isabel Lorda-Sanchez; Maria José Trujillo-Tiebas; Ester Carreño; Belen Jimenez-Rolando; Blanca Garcia-Sandoval; Marta Corton; Almudena Avila-Fernandez; Carmen Ayuso
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-02-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.